BAL PHARMA
|
The Current P/E Ratio of BAL PHARMA is 22.17.
| Share Price | ₹88.1 | Aug 04,2026 |
| Market Cap | ₹140.1 Cr | |
| Earnings-TTM | ₹6.3 Cr | TTM-Consolidated Results |
| Price/Earnings | 22.17x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of BAL PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹140.1 Cr] as on Aug 04,2026
(/) Earnings [ ₹6.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 22.17x ]
Thus, for BAL PHARMA , the investors are currently willing to pay 22.17 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BAL PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BAL PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of BAL PHARMA
PE Ratio Performance Analysis for BAL PHARMA
- BAL PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 24.80x.
- BAL PHARMA 's operated at median p/e ratio of 19.51x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAL PHARMA 's p/e ratio peaked in Mar2023 at 40.83x.
- BAL PHARMA 's p/e ratio hit its five-year low in Mar2021 of 16.8x.
How does BAL PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| BAL PHARMA | 6.32 | 22.17 | 140.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 38.63 | 470,270.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 75.97 | 222,224.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 88.74 | 191,325.0 |
| CIPLA LTD | 3,364.84 | 34.81 | 117,139.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 30.57 | 96,876.6 |
| MANKIND PHARMA LTD | 2,055.11 | 49.46 | 101,638.0 |
| LUPIN LTD | 5,355.47 | 20.29 | 108,639.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.20 | 111,571.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 26.03 | 91,128.4 |
| LAURUS LABS LTD | 1,090.76 | 90.92 | 99,174.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BAL PHARMA 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 20.29x |
| Max industry PE | 90.92x |
| Median industry PE | 34.81x |
| Average industry PE | 45.43x |
You may also like the below Video Courses